CRISPR-based nasal spray shows promise blocking respiratory viruses in early human trial
A CRISPR-based nasal spray reported encouraging findings in an early human trial. Investigators observed signals consistent with antiviral activity. Participants tolerated the spray without serious safety concerns. The results support…
